806 related articles for article (PubMed ID: 33166429)
21. COVID-19 and cutaneous manifestations: A review of the published literature.
Martora F; Villani A; Fabbrocini G; Battista T
J Cosmet Dermatol; 2023 Jan; 22(1):4-10. PubMed ID: 36342945
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology and clinical evolution of non-multisystem inflammatory syndrome (MIS-C) dermatological lesions in pediatric patients affected by SARS-CoV-2 infection: A systematic review of the literature.
Dondi A; Sperti G; Gori D; Guaraldi F; Montalti M; Parini L; Piraccini BM; Lanari M; Neri I
Eur J Pediatr; 2022 Oct; 181(10):3577-3593. PubMed ID: 35948654
[TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines.
Ronconi G; Teté G; Kritas SK; Gallenga CE; Caraffa Al; Ross R; Conti P
J Biol Regul Homeost Agents; 2020 May-June,; 34(3):767-773. PubMed ID: 32476380
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous Manifestations of COVID-19: A Systematic Review.
Singh H; Kaur H; Singh K; Sen CK
Adv Wound Care (New Rochelle); 2021 Feb; 10(2):51-80. PubMed ID: 33035150
[No Abstract] [Full Text] [Related]
25. Covid-19 skin manifestations: an update.
Sanchez-Flores X; Huynh T; Huang JT
Curr Opin Pediatr; 2021 Aug; 33(4):380-386. PubMed ID: 34127574
[TBL] [Abstract][Full Text] [Related]
26. [Cutaneous Manifestations Associated with COVID-19: A Narrative Review].
Relvas M; Calvão J; Oliveira R; Cardoso JC; Gonçalo M
Acta Med Port; 2021 Feb; 34(2):128-136. PubMed ID: 33315008
[TBL] [Abstract][Full Text] [Related]
27. Shock and Myocardial Injury in Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection: What We Know. Case Series and Review of the Literature.
Caro-Patón GL; de Azagra-Garde AM; García-Salido A; Cabrero-Hernández M; Tamariz A; Nieto-Moro M
J Intensive Care Med; 2021 Apr; 36(4):392-403. PubMed ID: 33148089
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous signs in COVID-19 patients: A review.
Wollina U; Karadağ AS; Rowland-Payne C; Chiriac A; Lotti T
Dermatol Ther; 2020 Sep; 33(5):e13549. PubMed ID: 32390279
[TBL] [Abstract][Full Text] [Related]
29. Overview of Dermatological Manifestations Associated with the COVID-19 Infection.
Patel H; Tran L; Feldman SR
Skin Therapy Lett; 2024 Mar; 29(2):7-9. PubMed ID: 38574264
[TBL] [Abstract][Full Text] [Related]
30. Top 10 acral skin manifestations associated with COVID-19: A scoping review.
Farajzadeh S; Khalili M; Dehghani S; Babaie S; Fattah M; Abtahi-Naeini B
Dermatol Ther; 2021 Nov; 34(6):e15157. PubMed ID: 34628708
[TBL] [Abstract][Full Text] [Related]
31. Hide and seek in a pandemic: review of SARS-CoV-2 infection and sequelae in children.
Clark JA; Pathan N
Exp Physiol; 2022 Jul; 107(7):653-664. PubMed ID: 34242467
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents.
Franulić D; Parać E; Dolački L; Topalušić I; Lugović-Mihić L
Acta Dermatovenerol Alp Pannonica Adriat; 2023 Dec; 32(4):173-181. PubMed ID: 38126100
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology, clinical profiles, and prognostic value of COVID-19-related cutaneous manifestations in African populations: a rapid narrative review.
Nyasulu PS; Tamuzi JL
Int J Dermatol; 2024 Jan; 63(1):10-22. PubMed ID: 37965793
[TBL] [Abstract][Full Text] [Related]
34. A comprehensive narrative review of the cutaneous manifestations associated with COVID-19.
Arefinia N; Ghoreshi ZA; Alipour AH; Iranmanesh B; Mehrolhasani N; Shamsi-Meymandi S; Sarvari J
Int Wound J; 2023 Mar; 20(3):871-879. PubMed ID: 36237171
[TBL] [Abstract][Full Text] [Related]
35. Acute urticaria preceding other COVID-19-associated manifestations-A case report.
Chen V; Escandon Brehm J; Bellodi Schmidt F
Pediatr Dermatol; 2021 Mar; 38(2):455-457. PubMed ID: 33410205
[TBL] [Abstract][Full Text] [Related]
36. Erythema multiforme as a consequence of COVID-19 infection.
Arndt M; Heath C; Healey B; Altman D
Dermatol Online J; 2021 Dec; 27(12):. PubMed ID: 35499442
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous Manifestations Related to COVID-19 Immune Dysregulation in the Pediatric Age Group.
Larenas-Linnemann D; Luna-Pech J; Navarrete-Rodríguez EM; Rodríguez-Pérez N; Arias-Cruz A; Blandón-Vijil MV; Del Rio-Navarro BE; Estrada-Cardona A; Onuma-Takane E; Pozo-Beltrán CF; Valencia-Herrera AM; Ortiz-Aldana FI; Toledo-Bahena ME
Curr Allergy Asthma Rep; 2021 Feb; 21(2):13. PubMed ID: 33630167
[TBL] [Abstract][Full Text] [Related]
38. Coronavirus disease 2019 (COVID-19): A systematic review of 133 Children that presented with Kawasaki-like multisystem inflammatory syndrome.
Keshavarz P; Yazdanpanah F; Azhdari S; Kavandi H; Nikeghbal P; Bazyar A; Rafiee F; Nejati SF; Sadabad FE; Rezaei N
J Med Virol; 2021 Sep; 93(9):5458-5473. PubMed ID: 33969513
[TBL] [Abstract][Full Text] [Related]
39. Clinical Patterns and Morphology of COVID-19 Dermatology.
Agnihothri R; Fox LP
Dermatol Clin; 2021 Oct; 39(4):487-503. PubMed ID: 34556240
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous manifestations in children with SARS-CoV-2 infection and/or COVID-19: what do we know after 10 months under this pandemic?
Li H; Zhao Y; Zhou L
Int J Dermatol; 2022 Jan; 61(1):39-45. PubMed ID: 34530491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
